Short Term Aspirin on the Biologic and Immunologic Changes of the Fallopian Tube

Inclusion Criteria: * Women undergoing gynecologic surgery for presumed benign indications that includes the removal of their fallopian tubes. This may include sterilization procedures, hysterectomy or partial or full adnexectomy. * Eligible women will have fulfilled their childbearing desires * Age \> 21 Considered low risk for prevalent fallopian tube cancer (not undergoing risk reducing surgery for a known BRCA mutation or other known hereditary predisposition syndrome, family history of ovarian cancer in a first degree relative. Exclusion Criteria: * Males * Women who have presumed or known gynecologic cancer * Women less than 21 years of age * Women currently on either regular aspirin therapy, non-steroidal anti-inflammatory drugs (NSAIDS), acetaminophen or chronic steroidal anti-inflammatory medications. * Women with known bleeding diathesis or bleeding disorder. * Women who do not consent for removal of both fallopian tubes. * Women with a history of gastritis or peptic ulcer disease requiring treatment. (Patients with a history of occasional H1 or H2 blocker use for gastro esophageal reflux disease are NOT excluded). * Women with reported aspirin or NSAID allergy * Women with asthma and/or nasal polyps